Fiore Mathieu, Tuffigo Marie, Cahoreau Véronique, Oses Pierre, Mouton Christine
Laboratory of Haematology, University Hospital of Bordeaux, Bordeaux, France.
Laboratory of Haematology, University Hospital of Bordeaux, Bordeaux, France.
Ann Thorac Surg. 2016 Nov;102(5):e423-e425. doi: 10.1016/j.athoracsur.2016.03.110. Epub 2016 Apr 7.
von Willebrand disease is a quantitative or qualitative deficiency of von Willebrand factor (VWF) that results in a significant risk of bleeding during surgical procedures unless precautions are taken. We describe for the first time 2 patients with type 2M and type 2N von Willebrand disease, respectively, who underwent coronary artery bypass grafting. Because of their high cardiovascular risk factors, replacement therapy was given at low doses with minimal postoperative bleeding.